Teladoc Health, Inc. (TDOC) Q3 2021 Earnings Results

Teladoc Health Misses on Revenue, Stock Down 1.89%

This earnings report indicates that while Teladoc Health exceeded EPS expectations, the lack of revenue data and no guidance may raise concerns among investors. The stock's decline of 1.89% reflects market apprehension about the company's future performance amidst ongoing challenges in the healthcare sector.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.53	N/A	+24.07%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious outlook while acknowledging the competitive landscape. They remain committed to strategic initiatives for future growth.

Management highlighted ongoing challenges in the market but remains focused on long-term growth.

They emphasized the importance of expanding their service offerings to meet evolving consumer needs.

Teladoc Health Misses on Revenue, Stock Down 1.89%

Key numbers

Management commentary

Teladoc Health, Inc.

More earnings this week

Teladoc Health Misses on Revenue, Stock Down 1.89%

Key numbers

Management commentary